Disposal
LONDON--(BUSINESS WIRE)--Nov. 21, 2002--
Tate & Lyle PLC - Disposal
Tate & Lyle PLC: Conditional sale of monosodium glutamate unit to Ajinomoto
Tate & Lyle PLC ('Tate & Lyle') announces that it has today entered
into an agreement for the sale of its monosodium glutamate (MSG)
production unit in France to Ajinomoto Co., Inc. ('Ajinomoto'). The
sale is conditional on approval by the competition authorities of a
number of countries.
The transaction will be the sale of the shares in Orsan S.A.
('Orsan'), held by Amylum France, a subsidiary of Tate & Lyle. These
shares represent 80.39% of the issued capital of Orsan (this
percentage will rise to 87.68% by the time of completion due to a
pre-completion reorganisation of Orsan). Ajinomoto is the minority
shareholder with, currently, 19.61% of the shares in issue (12.32% by
the time of completion). Orsan operates the MSG plant adjacent to the
Amylum France wheat processing plant in Nesle. The Orsan and Amylum
France operations have been fully segregated so Amylum France will not
be affected by the sale operationally, although it will continue to
provide utilities, feed stock and other services to Ajinomoto under
long term agreements.
The sale excludes Orsan's 51% shareholding in Orsan Guangzhou Gourmet
Powder Company Limited ('Orsan China') which produces MSG in China.
At 31March 2002, Orsan S. A. (excluding Orsan China) had a total net
asset value of £42 million and losses before tax attributable to these
net assets in the 12 months to 31 March 2002 amounted to £6.5 million.
In the six months to 30 September 2002, the business broke even.
Proceeds of the sale will be used to reduce Group debt.
The anticipated loss on disposal will be £14.5 million (which includes
£9.1 million of goodwill previously written off to reserves)
Larry Pillard, Tate & Lyle PLC Chief Executive comments: 'The disposal
is another step in Tate & Lyle's ongoing strategy to divest of
non-core or underperforming businesses and product lines.'
For more information contact:
Mark Robinson 020 7626 6525
Short Name: Tate & Lyle PLC
Category Code: DIS
Sequence Number: 00001267
Time of Receipt (offset from UTC): 20021121T082735+0000
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.